Literature DB >> 20472347

Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.

Karen Lim1, William Small, Lorraine Portelance, Carien Creutzberg, Ina M Jürgenliemk-Schulz, Arno Mundt, Loren K Mell, Nina Mayr, Akila Viswanathan, Anuja Jhingran, Beth Erickson, Jennifer De los Santos, David Gaffney, Catheryn Yashar, Sushil Beriwal, Aaron Wolfson, Alexandra Taylor, Walter Bosch, Issam El Naqa, Anthony Fyles.   

Abstract

PURPOSE: Accurate target definition is vitally important for definitive treatment of cervix cancer with intensity-modulated radiotherapy (IMRT), yet a definition of clinical target volume (CTV) remains variable within the literature. The aim of this study was to develop a consensus CTV definition in preparation for a Phase 2 clinical trial being planned by the Radiation Therapy Oncology Group. METHODS AND MATERIALS: A guidelines consensus working group meeting was convened in June 2008 for the purposes of developing target definition guidelines for IMRT for the intact cervix. A draft document of recommendations for CTV definition was created and used to aid in contouring a clinical case. The clinical case was then analyzed for consistency and clarity of target delineation using an expectation maximization algorithm for simultaneous truth and performance level estimation (STAPLE), with kappa statistics as a measure of agreement between participants.
RESULTS: Nineteen experts in gynecological radiation oncology generated contours on axial magnetic resonance images of the pelvis. Substantial STAPLE agreement sensitivity and specificity values were seen for gross tumor volume (GTV) delineation (0.84 and 0.96, respectively) with a kappa statistic of 0.68 (p < 0.0001). Agreement for delineation of cervix, uterus, vagina, and parametria was moderate.
CONCLUSIONS: This report provides guidelines for CTV definition in the definitive cervix cancer setting for the purposes of IMRT, building on previously published guidelines for IMRT in the postoperative setting. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20472347     DOI: 10.1016/j.ijrobp.2009.10.075

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  105 in total

1.  Repeat CT-scan assessment of lymph node motion in locally advanced cervical cancer patients.

Authors:  Luiza Bondar; Laura Velema; Jan Willem Mens; Ellen Zwijnenburg; Ben Heijmen; Mischa Hoogeman
Journal:  Strahlenther Onkol       Date:  2014-08-27       Impact factor: 3.621

2.  Development of a software for quantitative evaluation radiotherapy target and organ-at-risk segmentation comparison.

Authors:  Jayashree Kalpathy-Cramer; Musaddiq Awan; Steven Bedrick; Coen R N Rasch; David I Rosenthal; Clifton D Fuller
Journal:  J Digit Imaging       Date:  2014-02       Impact factor: 4.056

3.  External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.

Authors:  François Lucia; Dimitris Visvikis; Martin Vallières; Marie-Charlotte Desseroit; Omar Miranda; Philippe Robin; Pietro Andrea Bonaffini; Joanne Alfieri; Ingrid Masson; Augustin Mervoyer; Caroline Reinhold; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-07       Impact factor: 9.236

Review 4.  Problems and solutions in IGRT for cervical cancer.

Authors:  Iván Ríos; Ilse Vásquez; Elsa Cuervo; Óscar Garzón; Johnny Burbano
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-26

5.  Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.

Authors:  Jen-Yu Cheng; Eng-Yen Huang; Shun-Neng Hsu; Chong-Jong Wang
Journal:  Br J Radiol       Date:  2016-10-06       Impact factor: 3.039

6.  The Stacked-Ellipse Algorithm: An Ultrasound-Based 3-D Uterine Segmentation Tool for Enabling Adaptive Radiotherapy for Uterine Cervix Cancer.

Authors:  Sarah A Mason; Ingrid M White; Susan Lalondrelle; Jeffrey C Bamber; Emma J Harris
Journal:  Ultrasound Med Biol       Date:  2020-01-08       Impact factor: 2.998

7.  Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results.

Authors:  Rosario Mazzola; Francesco Ricchetti; Alba Fiorentino; Niccolò Giaj Levra; Sergio Fersino; Gioacchino Di Paola; Ruggero Ruggieri; Filippo Alongi
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

8.  Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study.

Authors:  Gabriella Macchia; Savino Cilla; Francesco Deodato; Francesco Legge; Aida Di Stefano; Vito Chiantera; Giovanni Scambia; Vincenzo Valentini; Alessio G Morganti; Gabriella Ferrandina
Journal:  Br J Radiol       Date:  2015-09-21       Impact factor: 3.039

9.  Radiation therapy oncology group gynecologic oncology working group: comprehensive results.

Authors:  David K Gaffney; Anuja Jhingran; Lorraine Portelance; Akila Viswanathan; Tracey Schefter; Joanne Weidhaas; William Small
Journal:  Int J Gynecol Cancer       Date:  2014-06       Impact factor: 3.437

10.  Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer.

Authors:  Ann H Klopp; Jennifer Moughan; Lorraine Portelance; Brigitte E Miller; Mohammad R Salehpour; Evangeline Hildebrandt; Jenny Nuanjing; David D'Souza; Luis Souhami; William Small; Rakesh Gaur; Anuja Jhingran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.